These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36584103)

  • 1. Heparin versus 0.9% sodium chloride intermittent flushing for preventing occlusion in newborns with peripherally inserted central catheters: A systematic review protocol.
    Nascimento APD; de Medeiros KS; Costa APF; Sarmento AC; Cruz GKP; Gonçalves AK; de Souza NL; Costa da Silva ML
    PLoS One; 2022; 17(12):e0278068. PubMed ID: 36584103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long-term central venous catheters in infants and children.
    Bradford NK; Edwards RM; Chan RJ
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010996. PubMed ID: 32352563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children.
    Bradford NK; Edwards RM; Chan RJ
    Cochrane Database Syst Rev; 2015 Nov; (11):CD010996. PubMed ID: 26590504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
    Shah P; Shah V
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002772. PubMed ID: 16034876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripherally inserted central catheter design and material for reducing catheter failure and complications.
    Schults JA; Kleidon T; Charles K; Young ER; Ullman AJ
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013366. PubMed ID: 38940297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults.
    López-Briz E; Ruiz Garcia V; Cabello JB; Bort-Marti S; Carbonell Sanchis R; Burls A
    Cochrane Database Syst Rev; 2014 Oct; (10):CD008462. PubMed ID: 25300172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
    Shah P; Shah V
    Cochrane Database Syst Rev; 2001; (3):CD002772. PubMed ID: 11687025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children: A systematic review.
    Bradford NK; Edwards RM; Chan RJ
    Int J Nurs Stud; 2016 Jul; 59():51-9. PubMed ID: 27222450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
    Shah PS; Shah VS
    Cochrane Database Syst Rev; 2008 Apr; (2):CD002772. PubMed ID: 18425882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study.
    Shah PS; Kalyn A; Satodia P; Dunn MS; Parvez B; Daneman A; Salem S; Glanc P; Ohlsson A; Shah V
    Pediatrics; 2007 Jan; 119(1):e284-91. PubMed ID: 17200252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of different flushing and locking techniques on catheter occlusion rates in central venous catheters: protocol for a multicentre, randomized controlled, parallel-group, open-label, superiority clinical trial.
    Li R; Zhou M; Sun L; Sha L; Xu B; Li T; Tao T; Yuan L
    Trials; 2024 Jun; 25(1):380. PubMed ID: 38867301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.
    López-Briz E; Ruiz Garcia V; Cabello JB; Bort-Martí S; Carbonell Sanchis R; Burls A
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD008462. PubMed ID: 30058070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripherally inserted central catheters inserted with current best practices have low deep vein thrombosis and central line-associated bloodstream infection risk compared with centrally inserted central catheters: A contemporary meta-analysis.
    Schears GJ; Ferko N; Syed I; Arpino JM; Alsbrooks K
    J Vasc Access; 2021 Jan; 22(1):9-25. PubMed ID: 32356479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT.
    Wu O; McCartney E; Heggie R; Germeni E; Paul J; Soulis E; Dillon S; Ryan C; Sim M; Dixon-Hughes J; Agarwal R; Bodenham A; Menne T; Jones B; Moss J
    Health Technol Assess; 2021 Jul; 25(47):1-126. PubMed ID: 34318743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripherally inserted central catheter versus central venous catheter for intravenous access: A protocol for systematic review and meta-analysis.
    Santos FKY; Flumignan RLG; Areias LL; Sarpe AKP; Amaral FCF; Ávila RB; Vasconcelos VT; Guedes Neto HJ; Amorim JE; Nakano LCU
    Medicine (Baltimore); 2020 Jul; 99(30):e20352. PubMed ID: 32791657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of complication rates between midline catheters and peripherally inserted central catheters: a systematic review and meta-analysis of randomized controlled trials.
    Lai JY; Wu MJ; Gautama MSN; Huang TW
    J Hosp Infect; 2024 Sep; 151():131-139. PubMed ID: 39032564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.
    Gilbert R; Brown M; Faria R; Fraser C; Donohue C; Rainford N; Grosso A; Sinha AK; Dorling J; Gray J; Muller-Pebody B; Harron K; Moitt T; McGuire W; Bojke L; Gamble C; Oddie SJ
    Health Technol Assess; 2020 Nov; 24(57):1-190. PubMed ID: 33174528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of peripherally inserted central catheter and other venous access devices: A scoping review.
    Wang K; Zhong J; Huang N; Zhou Y
    J Vasc Access; 2020 Nov; 21(6):826-837. PubMed ID: 31894710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A meta-analysis of the comparison of phlebitis between midline catheters and peripherally inserted central catheters in infusion therapy.
    Lu H; Yang Q; Tian B; Lyu Y; Zheng X; Xin X
    Int J Nurs Pract; 2022 Apr; 28(2):e12976. PubMed ID: 34075655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.